Atlas Trials

Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study

Clinical trial NCT07495384 · RECRUITING

Trial details

NCT number
NCT07495384
Sponsor
The First Hospital of Jilin University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent Ovarian CancerPlatinum Resistance
Start date
2025-01-17
Primary completion
2029-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.